Independent
Tenure on this board
2.9 yrs
6 nominees · 4 ballot items.
Stockholders will vote on four proposals at the AEON Biopharma, Inc. special meeting: PIPE Financing Proposal, Exchange Proposal, Equity Plan Proposal, and Adjournment Proposal; all four are recommended FOR by the Board.
Approval of issuance and sale of 4,616,924 shares of Common Stock (or pre-funded warrants), warrants to purchase 6,581,829 shares of Common Stock, and related True-Up Warrants, as part of the PIPE financing.
Approval of the exchange of the outstanding Daewoong senior secured convertible notes for (i) shares of Common Stock or pre-funded warrants, (ii) a new senior secured convertible note of $1,500,000, and (iii) a warrant to purchase 8,000,000 shares of Common Stock.
Approval of the Amended and Restated 2023 Incentive Award Plan (Equity Plan), increasing the authorized shares for grants and adding governance provisions (e.g., no repricing, director limits, and vesting provisions).
Approval of adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes for the other proposals.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Dauntless Investment Group, LLC | 9.61% | 2,527,775 | $2M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 0.34% | 90,529 | $89K |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 0.24% | 61,973 | $61K |
| 4 | Blue Owl Capital Holdings LP | 0.16% | 42,353 | $42K |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 0.10% | 25,089 | $25K |
| 6 | XTX Topco Ltd | 0.08% | 20,424 | $20K |
| 7 | Formidable Asset Management, LLC | 0.08% | 20,024 | $22K |
| 8 | JANE STREET GROUP, LLC | 0.06% | 16,330 | $16K |
| 9 | VANGUARD FIDUCIARY TRUST CO | 0.06% | 14,702 | $14K |
| 10 | LPL Financial LLC | 0.04% | 11,507 | $11K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.